Zelira faces ASX removal after failing to pay listing fee by Adam Sheldon August 24, 2026August 24, 2026 Zelira Therapeutics is facing removal from the Australian Securities Exchange (ASX) after failing to pay its […]
Argent shares soar after CannEpil deal wipes out US$5.5m debt by Adam Sheldon July 7, 2026July 7, 2026
Replacement funding falls through as Nexalis studies remain suspended by Adam Sheldon July 6, 2026July 9, 2026
Court clears LGP-Cannatrek merger ahead of June implementation by Adam Sheldon May 26, 2026May 27, 2026
Ex-Vitura CEO Geoff Cockerill sues firm over termination by Adam Sheldon and Steve Jones May 20, 2026May 22, 2026
TGA agreement on alleged ad breaches clears key hurdle in LGP-Cannatrek merger by Adam Sheldon May 11, 2026May 11, 2026
Domestic market could ‘double’ on back of driving law reform: Bioxyne by Adam Sheldon March 25, 2026March 25, 2026
